S1 Table -

Previous grouping of the original CVI patients (0–4) and after re-grouping of patients in Cohort 1 (A-D). The groups represents both the groups of patients from the previous CVI study (Groups 0–4) and the regrouping of Cohort 1 (Group A-D) in the current study for the statistical calculations based on the outcome of key parameters, i.e., patients who met the criteria for PTLDS, serological outcomes and laboratory signs of inflammation.
(XLSX)